retatrutide ly3437943 parkinson's disease clinical trial Glucagon-like peptide-1 receptor: mechanisms and advances in therapy LY3437943, a novel triple glucagon,

Pancreatic cancer has received particular attention due to the pancreatic expression of GLP-1 receptors and early concerns about pancreatitis potentially increasing cancer risk

Join Keith Nunes, editor, Food Business News

For retatrutide specifically, the retatrutide dosage calculator can help determine appropriate reconstitution volumes based on vial sizes and target concentrations

Our GLP-1 friendly food range includes dishes to support smaller portions while keeping you full and energised

Weight-loss drugs curb your appetite, so people taking medications like GLP-1 Agonist may have difficulty getting all the macronutrients, micronutrients or physical activity they need for optimal muscular, cardiovascular and brain health, said Kent Bradley, M.D., MBA, MPH, chief health and nutrition officer at Herbalife

Long-term monitoring after getting off GLP-1 The monitoring does not end after 90 days